Abstract:Alcohol exposure is a major reason of morbidity and mortality all over the world, with much of detrimental consequences attributing to alcoholic liver disease (ALD). With the continued ethanol consumption, alcoholic fatty liver disease (AFLD, the earliest and reversible form of ALD) can further develop to more serious forms of alcoholic liver damage, including alcoholic steatohepatitis, fibrosis/cirrhosis, and even eventually progress to hepatocellular carcinoma and liver failure. Furthermore, cell trauma, inflammation, oxidative stress, regeneration, and bacterial translocation are crucial promoters of ethanol-mediated liver lesions. AFLD is characterized by excessive fat deposition in liver induced by excessive drinking, which is related closely to the raised synthesis of fatty acids and triglyceride, reduction of mitochondrial fatty acid β-oxidation, and the aggregation of very-low-density lipoprotein (VLDL). Although little is known about the cellular and molecular mechanisms of AFLD, it seems to be correlated to diverse signal channels. Massive studies have suggested that liver steatosis is closely associated with the inhibition of silent information regulator 1 (SIRT1) and the augment of lipin1 β/α ratio mediated by ethanol. Recently, serine/arginine-rich splicing factor 10 (SFRS10), a specific molecule functioning in alternative splicing of lipin 1 (LPIN1) pre-mRNAs, has emerged as the central connection between SIRT1 and lipin1 signaling. It seems a new signaling axis, SIRT1–SFRS10–LPIN1 axis, acting in the pathogenesis of AFLD exists. This article aims to further explore the interactions among the above three molecules and their influences on the development of AFLD. Impact statement ALD is a major health burden in industrialized countries as well as China. AFLD, the earliest and reversible form of ALD, can progress to hepatitis, fibrosis/cirrhosis, even hepatoma. While the mechanisms, by which ethanol consumption leads to AFLD, are complicated and multiple, and remain incompletely understood. SIRT1, SFRS10, and LIPIN1 had been separately reported to participate in lipid metabolism and the pathogenesis of AFLD. Noteworthy, we found the connection among them via searching articles in PubMed and we had elaborated the connection in detail in this minireview. It seems a new signaling axis, SIRT1–SFRS10–LIPIN1 axis, acting in the pathogenesis of AFLD exists. Further study aimed at SIRT1–SFRS10–LIPIN1 signaling system will possibly offer a more effective therapeutic target for AFLD.

Deciphering the role of LncRNA in alcoholic liver disease: Mechanisms and therapeutic potential

Noncoding RNAs in Alcoholic Liver Disease

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Is the Hypoxia-Inducible Factor-1 Alpha Mrna Expression Activated by Ethanol-Induced Injury, the Mechanism Underlying Alcoholic Liver Disease?

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Alcohol and the mechanisms of liver disease

Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

Pattern of Microrna Expression Associated with Different Stages of Alcoholic Liver Disease in Rat Models

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease

Roles of silent information regulator 1–serine/arginine-rich splicing factor 10–lipin 1 axis in the pathogenesis of alcohol fatty liver disease

Targeting Inflammation for the Treatment of Alcoholic Liver Disease.

New Drug Targets for Alcoholic Liver Disease

Single-cell Profiling of Intrahepatic Immune Cells Reveals an Expansion of Tissue-resident Cytotoxic CD4+ T Lymphocyte Subset Associated With Pathogenesis of Alcoholic-associated Liver Diseases

The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD

Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease

Molecular insights on intracellular Wnt/β‐catenin signaling in alcoholic liver disease

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

Role of Inflammatory Factors in Development and Progression of Alcoholic Liver Disease

Epigenetic Modification in Alcohol‐related Liver Diseases

Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression